About EDAP TMS Investors Information Products & Services Clinical Information Press Careers Home / Clinical Information / Prostate cancer Prostate cancer What is prostate cancer and how can it be treated? Prostate cancer is the fourth most common cancer in both sexes combined and the second most common cancer in men. An estimated 1.1 million men worldwide were diagnosed with prostate cancer in 2012, accounting for 15% of the cancers diagnosed in men, with almost 70% of the cases (759,000) occurring in more developed regions. With an estimated 307,000 deaths in 2012, prostate cancer is the fifth leading cause of death from cancer in men (6.6% of the total men deaths). (source: World Health Organization, GLOBOCAN 2012) Introduction HIFU treatment Articles Abstracts & Posters The prostate Prostate cancer Assessment & diagnosis Treatment for localized prostate cancer * Ablatherm® Robotic HIFU and Focal One® are CE marked and indicated in Europe and other parts of the world outside of the US for the treatment of localized Prostate Cancer. In the United States, Ablatherm® Robotic HIFU and Focal One® are indicated for the ablation of prostate tissue. For more information, please contact us. ExactVu™ micro-ultrasound system is available for sale in the European Union (CE Mark), the United States (FDA 510(k) clearance), and in Canada (Health Canada license). It can be subject to local regulations. For more information, please contact us. HIFU can be subject to local regulations. For more information, please contact us. Clinical Information Prostate cancer Urinary stones Hemiablation study HIFU Prostate website was set up to provide patients with useful information relating to prostate conditions and particularly on the HIFU procedure. Link Contact us Company A tradition of Innovation EDAP TMS Overview Jobs & Career Contact us Products Focal One® ExactVU® Sonolith® i-move Laserlith® i-dust Services HIFU Services ESWL Services Customer Care Center Training EDAP TMS Websites EDAP TMS Japan HIFU patient web site ©EDAP TMS 2014-2021 Terms of Use Transparence Contact If you continue to browse this website, you are allowing all third-party services ✓ OK, accept all Personalize